Abstract:Xiaojun Zhang, 1 Lusheng Jiang, 2 Huimin Liu 3 1 Department of Cardiology, Shandong Rongjun General Hospital, Jinan, 250013, People's Republic of China; 2 Department of Emergency, Shandong Rongjun General Hospital, Jinan, 250013, People's Republic of China; 3 Blood Purification Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250011, People's Republic of China Correspondence: Huimin Liu Blood Purification Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No. 42, Wenhua West Road, Lixia District, Jinan, 250011, Shandong Province, People's Republic of China Tel +86 531 6861 7808 Email Forkhead box protein O1 (FoXO1) is a transcription factor involved in the regulation of a wide variety of physiological process including glucose metabolism, lipogenesis, bone mass, apoptosis, and autophagy. FoXO1 dysfunction is involved in the pathophysiology of various diseases including metabolic diseases, atherosclerosis, and tumors. FoXO1 activity is regulated in response to different physiological or pathogenic conditions by changes in protein expression and post-translational modifications. Various modifications cooperate to regulate FoXO1 activity and FoXO1 target gene transcription. In this review, we summarize how different post-translational modifications regulate FoXO1 physiological function, which may provide new insights for drug design and development. Keywords: forkhead box protein O1, post-translational modification, transcription The forkhead box (FoX) family mainly function as transcription factors characterized by a conserved DNA-binding domain (the Forkhead box). 1 The human FoX O class (FoXOs) belong to FoX family and plays a crucial role in energy metabolism, differentiation, apoptosis, cellular proliferation, stress. 2 , 3 FoXO subfamily includes four members: FoXO1, FoXO3, FoXO4, and FoXO6, which are encoded by four different genes and represent functional diversity in regulation of cellular processes. 1 , 3 FoXO1 is a transcription factor involved in the regulation of a wide variety of physiological process including glucose metabolism, lipogenesis, apoptosis, and autophagy. 4–7 FoXO1 dysfunction is involved in the pathophysiology of various diseases including metabolic diseases, atherosclerosis, and tumors. 2 , 8–10 The Human FoXO1 gene is located at chromosomal location 13q14.11 and encodes a 655 amino acid (aa) protein. 11–13 FoXO1 tissue expression is ubiquitous and within the cell FoXO1 distribution is cytoplasmic or nuclear. The cellular distribution of FoXO1 depends on the internal environment and homeostasis. Nuclear FoXO1 binds to cis-acting response elements of downstream target genes to mediate its transcription-regulatory function. 12 , 14–16 The FoXO1 protein comprises several functional domains, or motifs, including a conserved NH2-terminal DNA binding domain (DBD, residues 158–237), a nuclear localization signal motif (NLS, residues 251–253), a nuclear export sequence motif (NES, residues 374–401), and a COOH-terminal transcription activation domain (TAD, residues 596–655). 1 DBD of FoXO1 is to recognize and bind to the consensus sequence of target gene promoter to activate transcription. NLS motif is responsible for transportation into the nucleus for transactivation, conversely, NES motif is to mediate transportation into the cytoplasm interacting with nuclear exportin-1 and 14-3-3 protein. 17 The FoXO1 TAD can bind to other regulatory proteins to co-repress or coactivate its function. 18 FoXO1 secondary structure includes four α-helices (α1, α2, α3, and α4), four β-strands (β1, β2, β3, and β4), one β turn, and two wing regions (W1 and W2). The domain or motif order in the protein is β1-α1-β2-α2-α4-α3-β3-β turn-wing 1-β4-wing 2, located at the N-terminus (residues 156–249) ( Figure 1 ). 1 , 15 , 18 Mutations or covalent alterations of residues may significantly affect FoXO1 conformation and flexibility, resulting in a functional change. 19 Figure 1 Schematic diagram of human FoXO1 domain alignment and secondary structure. The residue numbers are shown for each FoXO1 domain. Abbreviatio -Abstract Truncated-

Mechanism of forkhead transcription factors binding to a novel palindromic DNA site

Mechanistic Insights into the Preference for Tandem Binding Sites in DNA Recognition by FOXM1

Toward a mechanistic understanding of DNA binding by forkhead transcription factors and its perturbation by pathogenic mutations

The forkhead DNA-binding domain binds specific G2-rich RNA sequences

Structural Basis for DNA Recognition by FOXG1 and the Characterization of Disease-causing FOXG1 Mutations

Domain tethering impacts dimerization and DNA-mediated allostery in the human transcription factor FoxP1

Unraveling the folding and dimerization properties of the human FoxP subfamily of transcription factors

FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations

Identification of Transcription Factor-Binding Sites in the Mouse FOXO1 Promoter

FoxO gene family evolution in vertebrates

Dynamic Conformational Change Regulates the Protein-Dna Recognition: an Investigation on Binding of A Y-Family Polymerase to Its Target Dna

Guiding the pioneer

The Role of Forkhead Box Family in Bone Metabolism and Diseases

DNA Conformation Induces Adaptable Binding by Tandem Zinc Finger Proteins

NMR investigation of FOXO4-DNA interaction for discriminating target and non-target DNA sequences

Structural basis for specific DNA sequence motif recognition by the TFAP2 transcription factors

Redirecting the pioneering function of FOXA1 with covalent small molecules

Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function.

Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target?

A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro

Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment